April 14, 2006
Southern Research Institute has been awarded more than $1.4 million by the National Institute of Allergy and Infectious Diseases to develop new high-throughput screening tools to expedite the search for antiviral drugs effective against influenza, including the H5N1 avian flu strain.
Infinity Pharmaceuticals has entered into a global strategic alliance with Novartis to discover, develop, and commercialize drugs targeting Bcl-2 protein family members for the treatment of a broad range of cancer indications. Members of the Bcl-2 family of proteins are known to facilitate cancer cell survival.
Northwestern University has joined Open Biosystems’ Open Access RNAi Program. Northwestern’s community of 270 participating research labs gains access to RNAi technology through Open Biosystems’ whole-genome lentiviral shRNAmir libraries.
The National Science Foundation has awarded a $500,000 grant to Evolutionary Genomics to continue developing a unique AIDS treatment based on successful adaptations in chimpanzees that keep HIV-type viruses from causing disease.